One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

Next-generation weight-loss pills could hit the market in the coming months, with new data raising a key question: Will ...

Two new JAMA Network Open studies link popular diabetes and weight loss drugs, including Ozempic and Mounjaro, to a slightly ...

Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...

In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...

People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical ...

The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...

Weight-loss drugs Mounjaro and Wegovy gain popularity among Indian diabetes patients. New research highlights rare but ...

Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...

In a phase 3 trial, the daily GLP-1 pill has shown "meaningful weight loss" and similar side effects to injectable GLP-1 ...

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...

A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...